Sustained virological response to interferon- plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients-Reference-Cited by-同舟云学术

Sustained virological response to interferon- plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients

Published:2011-01-14 Issue:3 Volume:66 Page:645-649
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:Journal of Antimicrobial Chemotherapy

Author:

Guzman-Fulgencio M.,Berenguer J.,Fernandez de Castro I.,Micheloud D.,Lopez J. C.,Cosin J.,Miralles P.,Lorente R.,Aldamiz-Echevarria T.,Munoz-Fernandez M. A.,Resino S.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/66/3/645/2183695/dkq518.pdf

Reference23 articles.

1. Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease

2. Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era

3. Hepatitis C Virus Infection and the Risk of Coronary Disease

4. Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotective effect of antiviral therapy among hepatitis C infected patients: A meta-analysis;IJC Heart & Vasculature;2023-12

2. Liver Stiffness Is Markedly Decreased After Chronic Hepatitis C Treatment;Ultrasound Quarterly;2022-03-04

3. Significance of Vascular Cell Adhesion Molecule-1 and Tumor Necrosis Factor-Alpha in HIV-Infected Patients;Journal of Clinical Medicine;2022-01-20

4. Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management;Minerva Medica;2021-04

5. Antiviral treatment for hepatitis C is associated with a reduced risk of atherosclerotic cardiovascular outcomes: A systematic review and meta‐analysis;Journal of Viral Hepatitis;2021-01-26